Itron, Inc. (NASDAQ:ITRI - Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $88.32 and last traded at $88.2010, with a volume of 420526 shares trading hands. The stock had previously closed at $93.54.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the stock. Guggenheim set a $155.00 price objective on shares of Itron in a research note on Friday, February 13th. Johnson Rice upgraded Itron from an "accumulate" rating to a "buy" rating and set a $130.00 target price on the stock in a report on Monday, January 5th. Wall Street Zen cut Itron from a "buy" rating to a "hold" rating in a research report on Wednesday, January 14th. Weiss Ratings downgraded Itron from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, January 12th. Finally, Oppenheimer increased their price objective on Itron from $125.00 to $133.00 and gave the company an "outperform" rating in a report on Wednesday, February 18th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Itron presently has an average rating of "Moderate Buy" and an average target price of $137.10.
Get Our Latest Research Report on Itron
Itron Stock Down 5.7%
The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of 13.55, a price-to-earnings-growth ratio of 0.80 and a beta of 1.44. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80. The business's 50 day moving average is $96.42 and its 200-day moving average is $105.05.
Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, topping analysts' consensus estimates of $2.19 by $0.27. The firm had revenue of $571.66 million during the quarter, compared to analyst estimates of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The business's revenue was down 6.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.35 EPS. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Equities analysts anticipate that Itron, Inc. will post 5.33 EPS for the current fiscal year.
Insider Buying and Selling at Itron
In related news, CFO Joan S. Hooper sold 15,293 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total transaction of $1,522,265.22. Following the completion of the sale, the chief financial officer owned 124,196 shares in the company, valued at $12,362,469.84. This represents a 10.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP John F. Marcolini sold 6,948 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total value of $691,603.92. Following the completion of the sale, the senior vice president directly owned 26,912 shares in the company, valued at $2,678,820.48. This trade represents a 20.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 51,180 shares of company stock worth $5,085,475 in the last ninety days. 1.45% of the stock is owned by insiders.
Institutional Investors Weigh In On Itron
Several hedge funds and other institutional investors have recently modified their holdings of ITRI. Vanguard Group Inc. boosted its holdings in Itron by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company's stock valued at $731,809,000 after purchasing an additional 132,329 shares during the period. Impax Asset Management Group plc increased its holdings in shares of Itron by 127.3% during the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company's stock worth $197,153,000 after purchasing an additional 890,040 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Itron by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company's stock valued at $118,034,000 after buying an additional 194,768 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Itron by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company's stock valued at $106,340,000 after buying an additional 6,598 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its stake in shares of Itron by 6.0% in the third quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company's stock valued at $124,545,000 after buying an additional 56,318 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.
About Itron
(
Get Free Report)
Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report